Salarius

Biotechnology company developing broad-spectrum antiviral peptide conjugate therapeutics

Built from URL

Houston

Artificial intelligence and machine learningHealthcarePharmaceuticals & MedicineClinical TrialsOncologyBiotechDrug Discovery

AboutBuilt from URL

Salarius is a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options. The company focuses on correcting dysregulated gene expression in cancer cells through two classes of drugs: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). They are currently in phase 1/2 trials with seclidemstat and in IND-enabling studies with SP-3164 for solid and hematologic cancers.

Problem

See something off about this company?